EUCTR2011-000833-35-IT进行中（未招募）不适用
A multicenter, phase II, double blind, randomized, parallel group, placebo-controlled study to evaluate the hemodynamic responses to intravenous RLX030 infusion in subjects with acute heart failure.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients admitted to hospital or who require admission to hospital for management of acute heart failure with shortness of breath at rest or minimal exertion - stabilized within 2 days after admission - normal or elevated systolic blood pressure - elevated pulmonary capilary wedge pressure measured by Swan-Ganz catheterization
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 35
排除标准
- •- severe renal impairment - significant liver impairment - significant lung impairment - significant heart valve dysfunction or arrythmias - myocardial infarction or acute coronary syndrome within th elast 45 days
研究者
相似试验
进行中（未招募）
不适用
Hemodynamic responses to intravenous RLX030 infusion in patients with acute heart failureAcute Heart FailureEUCTR2011-000833-35-DEovartis Pharma Services AG70
进行中（未招募）
不适用
Hemodynamic responses to intravenous RLX030 infusion in patients with acute heart failureMedDRA version: 14.1Level: LLTClassification code 10000803Term: Acute heart failureSystem Organ Class: 10007541 - Cardiac disordersAcute Heart FailureEUCTR2011-000833-35-NLovartis Pharma Services AG70
招募中
2 期
A clinical study of norketotifen capsule 4 mg in the treatment patients with mild to moderate atopic dermatitis.CTRI/2024/02/062891Bridge Pharma Inc
进行中（未招募）
1 期
Phase 2 trial, conducted in more than one site, in which no one knows the treatment assigned to the patient to evaluate the effect against pain and the safety of of the study drug, DFL24412, respect a control drug (Ketoprofen Lysine Salt, in patient with chronic low back paiChronic Low Back PainMedDRA version: 21.0Level: LLTClassification code 10052430Term: Chronic lumbagoSystem Organ Class: 100000004859EUCTR2021-001629-38-ITDOMPé FARMACEUTICI S.P.A.150
进行中（未招募）
1 期
Phase 2 trial, conducted in more than one site, in which no one knows the treatment assigned to the patient to evaluate the effect against pain and the safety of the study drug, DFL24412, respect a control drug (Ketoprofen Lysine Salt), in patient with chronic low back paiChronic Low Back PainMedDRA version: 21.0Level: LLTClassification code 10052430Term: Chronic lumbagoSystem Organ Class: 100000004859EUCTR2021-001629-38-ESDompè Farmaceutici S.p.A.150